2bullMeDiTherapy

2bullMeDiTherapy is a company specializing in the development of In-Vitro Diagnostic Medical Devices. Their primary focus is on the early detection and monitoring of aortic aneurysms. The company is located in Patras, Greece, with its address at Trion Navarchon 32, 262 22. 2bullMeDiTherapy aims to provide diagnostic solutions that are accurate, safe, and cost-effective. These solutions are designed to enhance therapeutic methodologies and improve patient quality of life. The company's operations are centered around the healthcare, pharmaceuticals, and biotechnology industries. 2bullMeDiTherapy's competitive advantages include the development of the first diagnostic blood test worldwide for thoracic and abdominal aortic aneurysms. This test offers a high degree of accuracy, efficiency, and safety. The company also emphasizes its comprehensive and competitive design, development, and production capabilities. 2bullMeDiTherapy's team includes Co-Founders Stavros Toumpoulis (President) and Prof. Ioannis Toumpoulis (Vice President). Zoi Zagoriti, a Biologist with an M.Sc., is also part of the team, along with Konstantina Tsiliganou, who serves as an assistant. The company also benefits from the expertise of Achilleas Gravanis, a Professor of Pharmacology at the School of Medicine, University of Crete, and a Researcher at IMBB-FORTH. Georgia Papathomas, an active investor, advisor, and board member with a focus on the healthcare and technology sectors, also contributes to the company's strategic direction. The company's core values and culture are centered around accuracy, efficiency, safety, innovation, and a client-first approach. 2bullMeDiTherapy can be contacted via email at [email protected].